Unexpected response to cisplatin rechallenge after immune checkpoint inhibitors in patients with metastatic urothelial carcinoma refractory to platinum regimen - Archive ouverte HAL Access content directly
Journal Articles European Journal of Cancer Year : 2018

Unexpected response to cisplatin rechallenge after immune checkpoint inhibitors in patients with metastatic urothelial carcinoma refractory to platinum regimen

Gwenaelle Gravis
Centre de Recherche en Cancérologie de Marseille
CV
Emilien Billon
  • Function : Author
Capucine Baldini
  • Function : Author
Christophe Massard
Werner Hilgers
Remy Delva
  • Function : Author
Jochen Walz
  • Function : Author
Geraldine Pignot
  • Function : Author
Stanislas Rybikowski
  • Function : Author
Slimane Dermeche
  • Function : Author
Jeanne Thomassin
  • Function : Author
Serge Brunelle
  • Function : Author
Pernelle Lavaud
Yohann Loriot
  • Function : Author
French Genito-Urinary Tumor Grp
  • Function : Author

Domains

Life Sciences [q-bio]

Ghislain Bidaut  : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-02143638

Submitted on : Wednesday, May 29, 2019-2:51:36 PM

Last modification on : Friday, March 24, 2023-2:53:11 PM

Not file

Dates and versions

hal-02143638 , version 1 (29-05-2019)

Identifiers

Cite

Gwenaelle Gravis, Emilien Billon, Capucine Baldini, Christophe Massard, Werner Hilgers, et al.. Unexpected response to cisplatin rechallenge after immune checkpoint inhibitors in patients with metastatic urothelial carcinoma refractory to platinum regimen. European Journal of Cancer, 2018, 104, pp.236-238. ⟨10.1016/j.ejca.2018.09.002⟩. ⟨hal-02143638⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS UNIV-AMU CRCM
31 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More